HIV-1 mutational pathways under multidrug therapy

BACKGROUND: Genotype-derived drug resistance profiles are a valuable asset in HIV-1 therapy decisions. Therapy decisions could be further improved, both in terms of predicting length of current therapy success and in preserving followup therapy options, through better knowledge of mutational pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawyer, Glenn, Altmann, André, Thielen, Alexander, Zazzi, Maurizio, Sönnerborg, Anders, Lengauer, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162516/
https://www.ncbi.nlm.nih.gov/pubmed/21794106
http://dx.doi.org/10.1186/1742-6405-8-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162516/
https://www.ncbi.nlm.nih.gov/pubmed/21794106
http://dx.doi.org/10.1186/1742-6405-8-26

Ejemplares similares